Are in you interested in knowing more about rules for interactions with HCP in France? This webinar offers you a compact overview on this topic, along with specifics required and rules you need to be aware of.
On-Demand | 1 hour | Your Desk! |
![]() |
Blandine BourrinetDirector, Regulatory Consulting and QMC Representative, PharmaLex |
There are various questions that need to be answered by companies considering operations with HCP, such as:
This webinar explores interactions with HCP and HCO and their global regulatory framework in France together with basic rules of disclosure of transfer of values.